Nabil et al.,2023 [31] Contrary, Qin et al. observed that EVI1 expression had no effect on CR rate among intermediate risk AML patients [15], and Marjanovic et al. [20] found that EVI1 + patients had higher CR rates compared to EVI1 in AML-NK patients. The gene discussed is MECOM; the disease is acute myeloid leukemia.